Back to Trials
NCT06420219Recruiting

An Integrative Multi-Omic Characterization of Head and Neck Carcinogenesis, Progression and Recurrence

University of Southern California

Start Date

3/25/2024

Completion Date

3/25/2029

Summary

This study evaluates the cell and biomarkers associated with the aggressive behavior of cancer.

Detailed Description

PRIMARY OBJECTIVE: I. High-resolution single-cell profiling of Cancer-associated fibroblasts (CAFs) in Human papillomavirus (HPV)+ Oropharyngeal Squamous Cell Carcinoma (OPSCC) and metastatic lymph nodes. OUTLINE: This is an observational study. Patients undergo photography, blood sample collection, tissue collection and have their medical records reviewed on study.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Diagnosis/disease status: New diagnosis of head and neck cancer * Allowable type and amount of prior therapy: No prior treatment * Age ≥ 18 years. * Ability to understand and the willingness to sign a written informed consent. Exclusion Criteria: * Patients who have had treatment of head and neck cancer

Interventions

OTHER

Non-Interventional Study

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Head and Neck Carcinoma

Locations

USC / Norris Comprehensive Cancer Center

Los Angeles, California 90033

United States